QRS duration and mortality in patients with congestive heart failure.
暂无分享,去创建一个
S. Fisher | Steven N. Singh | R. Fletcher | Ross D Fletcher | P. Karasik | Susan G Fisher | Stephen Iuliano | Pamela E Karasik | Steven N Singh | S. Iuliano | R. Fletcher
[1] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[2] D. Bonaduce,et al. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. , 1999, American heart journal.
[3] G. Dangas,et al. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. , 1998, Journal of the American College of Cardiology.
[4] B. Pitt,et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.
[5] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[6] M J Walsh,et al. Natural history of isolated bundle branch block. , 1996, The American journal of cardiology.
[7] P C Deedwania,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.
[8] M. Rich,et al. CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults , 1997, Journal of the American Geriatrics Society.
[9] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[10] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[11] S. Boveda,et al. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. , 1998, European heart journal.
[12] P. Armstrong,et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. , 1999, American heart journal.
[13] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[14] J. Albenque,et al. Prognostic value of late potentials in patients with congestive heart failure. , 1996, European heart journal.
[15] W. Mckenna,et al. Repolarization Aiternans: Techniques, Mechanisms, and Cardiac Vulnerability , 1997, Pacing and clinical electrophysiology : PACE.
[16] H. Doval,et al. Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.
[17] E. Botvinick,et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. , 2000, Journal of the American College of Cardiology.
[18] M. Tecce,et al. Heart failure: clinical implications of systolic and diastolic dysfunction. , 1999, Geriatrics.